Wells Fargo analyst Mohit Bansal maintained a Buy rating on Travere Therapeutics yesterday and set a price target of $65.00. Designed for personal research, portfolio monitoring, and AI-assisted ...
EVEREST MED (01952.HK) announced that its wholly owned subsidiary, Everest Medicines (Singapore) Pte. Ltd., as licensor, has ...
Stock Market Today: The Dow Jones index rises Friday on U.S.-Iran peace deal hopes. SpaceX stock jumps on its debut.